{"id":544132,"date":"2025-06-30T10:18:52","date_gmt":"2025-06-30T14:18:52","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid="},"modified":"2025-10-09T09:49:38","modified_gmt":"2025-10-09T13:49:38","slug":"integration-des-antagonistes-nk3-en-pratique-clinique-2","status":"publish","type":"product","link":"https:\/\/www.mdbriefcase.com\/fr\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=","title":{"rendered":"Int\u00e9gration des antagonistes NK3 en pratique clinique"},"content":{"rendered":"<p dir=\"ltr\" style=\"text-align: left;\">Les antagonistes du r\u00e9cepteur NK3 constituent une nouvelle option pour le traitement des sympt\u00f4mes vasomoteurs (SVM) associ\u00e9s \u00e0 la m\u00e9nopause. Ce programme de formation couvre les consid\u00e9ration pratiques dont il faut tenir compte lors de la prescription de cette nouvelle classe de m\u00e9dicaments, incluant la posologie, les effets ind\u00e9sirables et les crit\u00e8res de surveillance. \u00c0 la fin de la session, le clinicien sera en confiance et en possession des connaissances n\u00e9cessaires pour int\u00e9grer cette nouvelle th\u00e9rapie dans sa pratique lorsqu\u2019elle sera appropri\u00e9e, suite \u00e0 une prise d\u00e9cisionnelle clinique efficace.\u00a0<\/p>\n<hr>\n<p dir=\"ltr\" style=\"text-align: left;\">Ce programme a b\u00e9n\u00e9fici\u00e9 d\u2019un soutien financier de la part de Astellas Pharma Inc. sous forme de bourse \u00e0 vis\u00e9e \u00e9ducative sans restriction.<\/p>","protected":false},"excerpt":{"rendered":"<p>Les antagonistes du r\u00e9cepteur NK3 constituent une nouvelle option pour le traitement des sympt\u00f4mes vasomoteurs (SVM) associ\u00e9s \u00e0 la m\u00e9nopause. Ce programme de formation couvre les consid\u00e9ration pratiques dont il faut tenir compte lors de la prescription de cette nouvelle classe de m\u00e9dicaments, incluant la posologie, les effets ind\u00e9sirables et les crit\u00e8res de surveillance. \u00c0 [&hellip;]<\/p>\n","protected":false},"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"product_brand":[],"product_cat":[],"product_tag":[],"class_list":{"0":"post-544132","1":"product","2":"type-product","3":"status-publish","6":"first","7":"instock","8":"downloadable","9":"virtual","10":"taxable","11":"purchasable","12":"product-type-simple"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Int\u00e9gration des antagonistes NK3 en pratique clinique - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Int\u00e9gration des antagonistes NK3 en pratique clinique - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Les antagonistes du r\u00e9cepteur NK3 constituent une nouvelle option pour le traitement des sympt\u00f4mes vasomoteurs (SVM) associ\u00e9s \u00e0 la m\u00e9nopause. Ce programme de formation couvre les consid\u00e9ration pratiques dont il faut tenir compte lors de la prescription de cette nouvelle classe de m\u00e9dicaments, incluant la posologie, les effets ind\u00e9sirables et les crit\u00e8res de surveillance. \u00c0 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-09T13:49:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=\",\"url\":\"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=\",\"name\":\"Int\u00e9gration des antagonistes NK3 en pratique clinique - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"datePublished\":\"2025-06-30T14:18:52+00:00\",\"dateModified\":\"2025-10-09T13:49:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop &#8211; Old\",\"item\":\"https:\/\/www.mdbriefcase.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Int\u00e9gration des antagonistes NK3 en pratique clinique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Int\u00e9gration des antagonistes NK3 en pratique clinique - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=","og_locale":"fr_CA","og_type":"article","og_title":"Int\u00e9gration des antagonistes NK3 en pratique clinique - MDBriefCase","og_description":"Les antagonistes du r\u00e9cepteur NK3 constituent une nouvelle option pour le traitement des sympt\u00f4mes vasomoteurs (SVM) associ\u00e9s \u00e0 la m\u00e9nopause. Ce programme de formation couvre les consid\u00e9ration pratiques dont il faut tenir compte lors de la prescription de cette nouvelle classe de m\u00e9dicaments, incluant la posologie, les effets ind\u00e9sirables et les crit\u00e8res de surveillance. \u00c0 [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=","og_site_name":"MDBriefCase","article_modified_time":"2025-10-09T13:49:38+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=","url":"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=","name":"Int\u00e9gration des antagonistes NK3 en pratique clinique - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"datePublished":"2025-06-30T14:18:52+00:00","dateModified":"2025-10-09T13:49:38+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid="]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/product\/integration-des-antagonistes-nk3-en-pratique-clinique-2\/?courseid=#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Shop &#8211; Old","item":"https:\/\/www.mdbriefcase.com\/shop\/"},{"@type":"ListItem","position":3,"name":"Int\u00e9gration des antagonistes NK3 en pratique clinique"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product\/544132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=544132"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=544132"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=544132"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=544132"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=544132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}